# ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

> **NCT05932615** · NA · ENROLLING_BY_INVITATION · sponsor: **Abbott Medical Devices** · enrollment: 1500 (estimated)

## Conditions studied

- Aortic Valve Stenosis
- Heart Valve Diseases
- Aortic Valve Disease
- Heart Disease Structural Disorder

## Interventions

- **DEVICE:** Navitor Transcatheter Aortic Valve Implantation (TAVI) System
- **DEVICE:** Any Commercially Available Transcatheter Aortic Valve (CAV) System

## Key facts

- **NCT ID:** NCT05932615
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-03-15
- **Primary completion:** 2027-04
- **Final completion:** 2036-04
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05932615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05932615, "ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05932615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*